Home » Topics » BioWorld Science

BioWorld Science
RSS

China NMPA grants conditional approval to toripalimab in nasopharyngeal carcinoma

Feb. 22, 2021

Study links antidepressant action to TRKB binding

Feb. 22, 2021

Targeting AMPK-alpha prevents drug-induced hair cell loss and hearing loss

Feb. 22, 2021

Dosing begins in phase II trial of BBP-418 for limb girdle muscular dystrophy type 2i

Feb. 22, 2021

European Commission approves Heplisav B

Feb. 22, 2021

Valneva initiates further phase III study of chikungunya vaccine candidate VLA-1553

Feb. 22, 2021

MMP-14 is a potential marker of vestibular schwannomas

Feb. 22, 2021

First-in-human data from SAD and MAD studies of LTI-291 in healthy volunteers

Feb. 22, 2021

Insmed reports phase I safety and PK data for treprostinil palmitil inhalation powder

Feb. 22, 2021

Positive topline data from pivotal phase III SKYLIGHT 1 and SKYLIGHT 2 studies of fezolinetant

Feb. 22, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...